HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


California Preps For SCP Priorities Selection, Eyeing Salon Nail Products

This article was originally published in The Rose Sheet

Executive Summary

The Department of Toxic Substances Control will host a webinar in November to solicit information on “nail salon products and chemicals,” among other topics, as the agency prepares to issue its second round of draft Priority Product selections under California’s Safer Consumer Products program.

You may also be interested in...

FDA: ‘Vast Majority’ Of Antibac Soaps Need Reformulation Under Final Rule

FDA/CDER’s Teresa Michele says the “vast majority” of roughly 2,100 consumer antibacterial soaps on the market contain at least one of 19 antimicrobial ingredients banned from OTC use under an FDA final rule. Industry, which suggests the agency is overstating the rule’s impact, is focused on delivering supporting data for three active ingredients still pending before FDA for GRASE use in the category.

California DTSC's Alternative Analyses Guide Falls Short Of Industry Needs

The Department of Toxic Substances Control's guidance for conducting the stage-1 alternatives analyses under California's Safer Consumer Products program lacks detail on the agency's "most basic internal process for evaluating data and other product information" to inform compliance decisions, industry coalitions say. The groups cite numerous areas in need of clarification in November comments to the agency.

N.Y. City Salon Crusade Includes Investigation Into Nail-Care Chemicals

New York's Department of Consumer Affairs, which is heading up a large-scale initiative to address reported labor exploitation and health risks in nail salons, has issued a letter to FDA seeking a ban on toluene, formaldehyde and dibutyl phthalate in nail products and intends to investigate manufacturers making "environmental and product claims that may not be valid."

Related Content


Latest Headlines
See All



Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts